Badania PLANET I i PLANET II Komentarz
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
mar 31, 2011
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
##plugins.themes.bootstrap3.article.details##
Jak cytować
Rozentryt , P. (2011). Badania PLANET I i PLANET II . Medycyna Faktów , 4(1(10), 17-19. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2544
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Myers G.L. et al.: Recommendations for Improving Serum Creatinine Measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin. Chem. 2006; 52: 5-18.
2. Camerino G.M. et al.: Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle. Biochemical Pharmacology [w druku].
3. Paiva H. et al.: High-dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial [ast]. Clin. Pharmacol. Ther. 2005; 78: 60-68.
4. Paulsen L. et al.: Acute Effects of Atorvastatin on Glomerular Filtration Rate, Tubular Function, Blood Pressure, and Vasoactive Hormones in Patients With Type 2 Diabetes. The Journal of Clinical Pharmacology 2010; 50: 816-822.
5. Gupta A., Thompson P.D.: The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis 2011; 215: 23-29.
6. de Zeeuw D. et al.: Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. The Lancet 2010; 376: 1543-1551.
7. Ott C., Titze S.I., Schäufele T., Schmieder R.E.: Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia. J. Nephrol. 2009; 22: 675-681.
2. Camerino G.M. et al.: Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle. Biochemical Pharmacology [w druku].
3. Paiva H. et al.: High-dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial [ast]. Clin. Pharmacol. Ther. 2005; 78: 60-68.
4. Paulsen L. et al.: Acute Effects of Atorvastatin on Glomerular Filtration Rate, Tubular Function, Blood Pressure, and Vasoactive Hormones in Patients With Type 2 Diabetes. The Journal of Clinical Pharmacology 2010; 50: 816-822.
5. Gupta A., Thompson P.D.: The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis 2011; 215: 23-29.
6. de Zeeuw D. et al.: Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. The Lancet 2010; 376: 1543-1551.
7. Ott C., Titze S.I., Schäufele T., Schmieder R.E.: Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia. J. Nephrol. 2009; 22: 675-681.